SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063379
Filing Date
2023-11-14
Accepted
2023-11-14 08:30:28
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-20230930.htm   iXBRL 10-Q 2153010
2 EX-31.1 apvo-ex31_1.htm EX-31.1 17880
3 EX-31.2 apvo-ex31_2.htm EX-31.2 18121
4 EX-32.1 apvo-ex32_1.htm EX-32.1 10899
5 EX-32.2 apvo-ex32_2.htm EX-32.2 11463
  Complete submission text file 0000950170-23-063379.txt   8021047

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apvo-20230930.xsd EX-101.SCH 55485
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apvo-20230930_pre.xml EX-101.PRE 344756
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apvo-20230930_cal.xml EX-101.CAL 34466
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apvo-20230930_lab.xml EX-101.LAB 432187
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apvo-20230930_def.xml EX-101.DEF 223277
58 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20230930_htm.xml XML 1283374
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 231401757
SIC: 2834 Pharmaceutical Preparations